Skip to main content
. 2022 Jul 7;159(1):65–79. doi: 10.1007/s11060-022-04044-1

Fig. 2.

Fig. 2

Change of cognitive functioning within a two-year follow-up. Graphs indicate mean cognitive performance (in percentile ranks) in NeuroCog FX subtests at baseline after surgery and at two-year follow-up, separated for dichotomized treatment groups. The asterisk indicates a statistically significant difference in cognitive change between groups; * p < 0.05; bars indicate standard error of mean. a Irradiated patients (RT+, radiotherapy only or combined radio-chemotherapy, n = 34) and non-irradiated patients (RT-, chemotherapy only or watch-and-wait, n = 52). b Patients with chemotherapy (ChT+, chemotherapy only or combined radio-chemotherapy, n = 45) and without chemotherapy (ChT-, radiotherapy only or watch-and-wait, n = 41)